RESUMO
Objetivos: Analizamos los factores pronósticos asociados a mortalidad en pacientes con absceso cerebral (AC) y la influencia del tratamiento antibiótico protocolizado (PA). Pacientes y Métodos: estudio observacional en un hospital universitario (1975-2005). El tratamiento antibiótico empírico se realizó sin PA (Periodo I -PI-, 1975-1983; n = 33) y de acuerdo a PA diseñado por los Servicios de MI-Infecciosas y Neurocirugía a partir de 1983 (Periodo II -PII-; n = 71); valoramos la influencia del Protocolo Terapéutico en la curación de los enfermos. Resultados: se evaluaron 104 pacientes (edad media 45 años; rango12-86); el origen del AC se identificó en 89% y en 76% hubo confirmación microbiológica. Mortalidad, 16,3% (17/104); se asociaron de forma estadísticamente significativa a mayor mortalidad: edad > 40 años, enfermedad de base últimamente fatal, situación clínica inicial crítica-mala, presencia de alteración del estado de conciencia y tratamiento empíricono adecuado. No hubo diferencias estadísticamente significativas en las características epidemiológicas, clínicas, radiológicas o microbiológicas de los pacientes correspondientes al PI y al PII, excepto en edad (> 40años, 36% en PI y 62% en PII); si hubo diferencias en curaciones, 60% vs 77% (p < 0,05); recidivas 21 vs. 7% (p < 0,05) y mortalidad 18 vs.15,4% (p > 0,05) en PI y PII, respectivamente. Conclusiones: La edad, enfermedad de base últimamente fatal, gravedad clínica inicial, presencia de alteración del nivel de conciencia y el tratamiento antibiótico empírico inadecuado son los principales factores pronósticos asociados a mayor mortalidad en pacientes con AC. La prescripción del tratamiento empírico de acuerdo con un PA consensuado se asoció con mayor porcentaje de curaciones y menor número de recidivas
Background: the aim of this study was to evaluate prognostic factors in brain abscess (AB) and influence of management with antibiotic prescribing protocols (APP). Patients and Methods: observational study of a cohort of non-paediatric patients with BA admitted at a 944-bed hospital (1976-2005). Data collection from clinical records has been done according to a standard protocol. We analysed epidemiological, clinical, radiological, microbiological and laboratory data associated with mortality. From1976 to 1983 (Period I), antibiotic treatment was not done according toany internal APP; from 1983 (Period II), antibiotic management was done according to a APP designed by infectious diseases specialists and neurosurgeons. Predictors of mortality were identified by univariate analysis. The influence of the use of APP in outcome was assessed. Results: 104 patients with BA were included (mean age 45 years;range 12-86); presumed primary pathogenic mechanism of BA was identified in 89%; microbiologic diagnosis was made in 76%. Overall mortality was 16.3%. Factors statistically associated with higher mortality were: age > 40 years, ultimately fatal underlying disease, acute severe clinical condition at the onset of BA, altered mental status and inadequate empirical treatment; 33 patients were treated in Period I and 71 in Period II; no statistically significant differences were found between epidemiological, clinical, radiological or microbiological characteristics of the groups except for mean age (> 40 years in 36% and 62% respectively in Period I and II). Rates of resolution of BA were 60 vs. 77.4% (p <0.05); relapses 21 vs. 7% (p < 0.05) and mortality 18 vs. 15.4% (p >0.05), in Period I and II respectively. Conclusions: main prognostic factors associated with mortality in patients with BA are age, rapidly fatal underlying disease, acute severe clinical condition at the onset of BA, altered mental status and inadequateempirical treatment. Empiric treatment according to APP was associated with greater resolution and lower relapse rates
